Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Ventyx Biosciences, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 144 Form 144 - Report of proposed sale of securities:
10/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002 in Patients with Moderate-to-Severely Active Ulcerative Colitis",
"Corporate Presentation"
10/05/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "Ventyx Biosciences, Inc. Condensed Consolidated Statements of Operations and Comprehensive Loss Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Operating expenses: Research and development $ 48,560 $ 14,676 $ 83,997 $ 32,085 General and administrative 8,585 5,722 15,700 11,060 Total operating expenses 57,145 20,398 99,697 43,145 Loss from operations Other expense: Interest income Other expense 5 6 79 Total other expense Net loss $ $ $ $ Unrealized gain on marketable securities 352 Foreign currency translation 38 61 Comprehensive loss $ $ $ $ Net loss per share, basic and diluted $ $ $ $ Weighted average common shares outstanding, basic and diluted 58,556,529 50,848,391 58,100,261 50,717,548 Ventyx Biosciences, Inc. Selected Condensed Consolidated Balance S..."
08/08/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/25/2023 8-K Quarterly results
07/25/2023 144 Form 144 - Report of proposed sale of securities:
07/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/11/2023 SC 13D/A NSV Investments I, L.P. reports a 14.6% stake in ——————— VENTYX BIOSCIENCES, INC.
07/07/2023 144/A Form 144/A - Report of proposed sale of securities: [Amend]
07/07/2023 144 Form 144 - Report of proposed sale of securities:
07/05/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
06/15/2023 144 Form 144 - Report of proposed sale of securities:
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
06/06/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy